MedTrace Logo

An Observational Study of Patients With Dermatologic Disease

NCT07748169 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000000

Last updated 2026-08-05

No results posted yet for this study

Summary

TARGET-DERM+ is an observational research study to conduct a comprehensive review of outcomes for patients with dermatologic disease (DD) and providers who treat these patients. The study includes patients managed for DD of any etiology in usual clinical practice in the United States and addresses important clinical questions regarding the management of DD by collecting and analyzing data from patients at academic medical centers and community medical practices and/or data from providers who treat them.

Conditions

Sponsors & Collaborators

  • Target PharmaSolutions, Inc.

    lead INDUSTRY

Principal Investigators

  • Laura Dalfonso · Pedestal Health

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-01
Primary Completion
2041-08-03
Completion
2041-08-03

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07748169 on ClinicalTrials.gov